SARS-CoV-2
Coronavirus disease (COVID-19) outbreak

Roche’s antibody test receives FDA Emergency Use Authorization

The Elecsys® Anti-SARS-CoV-2 immunoassay can help determine if a patient has been exposed to the virus which causes COVID-19 and if the patient has developed antibodies against SARS-CoV-2.

Find Testing Sites

logo

We stand in solidarity
What we challenge, we change. Roche stands with the Black community against racism, violence and injustice.

SARS-CoV-2

Stay up to date on Roche’s response to COVID-19 (Coronavirus)

Access helpful resources such as customer communications, fact sheets, frequently asked questions, testing information and follow along with our blog.

Learn more

SARS-CoV-2

Real-time RT-PCR test

Detecting SARS-CoV-2 in currently infected patients with high sensitivity

The cobas® SARS-CoV-2 for use on the cobas® 6800/8800 Systems is a real-time RT-PCR test intended for the qualitative detection of nucleic acids from SARS-CoV-2 in clinician-instructed self-collected nasal swab specimens (collected on site), and clinician-collected nasal, nasopharyngeal, and oropharyngeal swab specimens from patients.

cobas® SARS-CoV-2 Test